“Patient money” is a term sometimes applied to private equity investors who can afford to let their investment ride for several years or more without making an exit to recoup returns.
The term continues to apply to one of shipping’s largest private investors, California-based Oaktree Capital Management. It has been increasing its stake in public dry bulk owners this year while maintaining large bets on product tankers and chemical carriers.
